Bharat Ravishankar, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Mohammed S Qayyum MD Inc · Dignity Health Medical Foundation
Looking this up.
Hospitals listed: Mercy Medical Center Redding. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ravishankar’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy Medical Center ReddingRedding, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Postoperative sepsis rate: 8.72 (5.3 to 12.13) · 512 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative wound dehiscence rate: 3.32 (1.96 to 4.68) · 627 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (11.2 to 17) · 393 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.25, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.2, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.36, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy Medical Center Redding
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 8.72 (5.3 to 12.13) · 512 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 3.32 (1.96 to 4.68) · 627 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (11.2 to 17) · 393 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.25 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.2 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.36 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.47 (0.64 to 2.31) · 1,952 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.23 (0.95 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.5 (161.15 to 233.85) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.4 · 260 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 310 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.4 · 523 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.3 · 566 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 430 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,127 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.02 to 0.38) · 9,685 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.37) · 9,685 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.74 to 5.18) · 2,333 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.08 (0.55 to 3.61) · 675 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (1 to 3.63) · 2,409 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.12 (3.94 to 16.3) · 683 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.85 (0.34 to 1.36) · 8,952 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.3 · 82 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.606 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.624 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.8 · 235 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 455 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.8 · 282 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.2 · 554 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 538 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 403 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.9 to 7.1) · 393 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 89 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.2 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 241 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15.8 (11.8 to 21.3) · 307 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 1,015 cases | No different | Jan 2024 – Dec 2024 |
What patients said (588 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 35% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
Drugs they prescribed that Part D paid
$29,088
Pharmacies billed $29,088 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 199) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
174 generic and 25 brand-name prescriptions · $29,088 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clopidogrel | 27 | $266 | $10 |
| Rosuvastatin | 14 | $174 | $12 |
| Atorvastatin | 16 | $145 | $9 |
| Losartan | 12 | $75 | $6 |
| Amlodipine Besylate | 14 | $57 | $4 |
See all 7 drugs
| Clopidogrel | 27 | $266 | $10 |
| Rosuvastatin | 14 | $174 | $12 |
| Atorvastatin | 16 | $145 | $9 |
| Losartan | 12 | $75 | $6 |
| Amlodipine Besylate | 14 | $57 | $4 |
| Lisinopril | 14 | $53 | $4 |
| Furosemide | 14 | $53 | $4 |
Year by year
| 2024 | 199 | 76 | 0% (0) | 13% | $29,088 |
| 2023 | 273 | 65 | 0% (0) | 16% | $65,261 |
| 2022 | 162 | 48 | 0% (0) | None | $38,742 |
| 2021 | 386 | 45 | 0% (0) | 16% | $102,062 |
| 2020 | 363 | 71 | None | 26% | $79,633 |
| 2019 | 763 | 168 | None | 25% | $89,544 |
| 2018 | 235 | 73 | None | None | $16,700 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Entresto | 13 | $25,082 | $1,929 |
| Metoprolol | 20 | $507 | $25 |
| Amlodipine Besylate | 25 | $296 | $12 |
| Spironolactone | 21 | $273 | $13 |
| Atorvastatin | 17 | $251 | $15 |
| Carvedilol | 22 | $198 | $9 |
| Furosemide | 23 | $176 | $8 |
2022: 4 drugs
| Entresto | 17 | $13,949 | $821 |
| Metoprolol | 22 | $335 | $15 |
| Atorvastatin | 12 | $208 | $17 |
| Amlodipine Besylate | 11 | $100 | $9 |
2021: 10 drugs
| Eliquis | 11 | $8,829 | $803 |
| Omega-3 Acid Ethyl Esters | 12 | $2,205 | $184 |
| Labetalol | 16 | $684 | $43 |
| Losartan | 13 | $266 | $20 |
| Gabapentin | 15 | $264 | $18 |
| Metoprolol | 16 | $194 | $12 |
| Amlodipine Besylate | 29 | $184 | $6 |
| Atorvastatin | 21 | $168 | $8 |
| Metformin | 16 | $121 | $8 |
| Hydrochlorothiazide | 14 | $49 | $4 |
2020: 5 drugs
| Labetalol | 11 | $250 | $23 |
| Duloxetine | 11 | $234 | $21 |
| Atorvastatin | 15 | $174 | $12 |
| Metoprolol | 12 | $129 | $11 |
| Amlodipine Besylate | 24 | $95 | $4 |
2019: 19 drugs
| Humulin N | 12 | $5,934 | $495 |
| Symbicort | 14 | $5,002 | $357 |
| Nifedipine Er | 13 | $893 | $69 |
| Alcohol Prep Pads | 18 | $856 | $48 |
| Albuterol Sulfate Hfa | 16 | $757 | $47 |
| Methotrexate | 19 | $572 | $30 |
| Atorvastatin | 40 | $536 | $13 |
| Pantoprazole | 30 | $482 | $16 |
| Omeprazole | 14 | $232 | $17 |
| Levothyroxine | 11 | $226 | $21 |
| Carvedilol | 21 | $193 | $9 |
| Lisinopril | 23 | $121 | $5 |
| Metoprolol | 20 | $105 | $5 |
| Methimazole | 12 | $97 | $8 |
| Furosemide | 23 | $96 | $4 |
| Metformin | 11 | $95 | $9 |
| Prednisone | 20 | $76 | $4 |
| Losartan | 11 | $75 | $7 |
| Amlodipine Besylate | 22 | $72 | $3 |
2018: 4 drugs
| Gabapentin | 18 | $145 | $8 |
| Pantoprazole | 14 | $121 | $9 |
| Amlodipine Besylate | 13 | $74 | $6 |
| Furosemide | 11 | $34 | $3 |
Money from drug and device companies
$1,280 in 2025
| 2025 | 5 | 23 | None | $1,280 |
| 2024 | 1 | 1 | None | $44 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Avvigo Guidance System | $669 | 10 payments
|
| Philips North America | Coronary Other | $303 | 3 payments
|
| Abbott Laboratories | Triclip | $249 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $38 | 2 payments
|
| Pfizer | Eliquis | $21 | 1 payment
|
See all 23 published payments
| Abbott Laboratories | Meals · 2025-10-06 | Dragonfly Opstar | $20 |
| Abbott Laboratories | Meals · 2025-07-17 | Dragonfly Opstar | $19 |
| Boston Scientific | Meals · 2025-06-25 | Avvigo Guidance System | $61 |
| Boston Scientific | Meals · 2025-06-23 | Comet | $5 |
| Boston Scientific | Meals · 2025-06-12 | General - Therapies | $155 |
| Pfizer | Meals · 2025-06-11 | Eliquis | $21 |
| Philips North America | Meals · 2025-06-10 | Coronary Other | $155 |
| Boston Scientific | Meals · 2025-06-04 | Ffr Link | $4 |
| Boston Scientific | Meals · 2025-06-03 | Wolverine Coronary Cutting Balloon | $4 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-14 | Jardiance | $17 |
| Philips North America | Meals · 2025-04-28 | Coronary Other | $3 |
| Boston Scientific | Meals · 2025-04-03 | Avvigo Guidance System | $174 |
| Abbott Laboratories | Meals · 2025-03-26 | Xience Skypoint | $23 |
| Abbott Laboratories | Meals · 2025-03-26 | Dragonfly Opstar | $22 |
| Abbott Laboratories | Meals · 2025-03-26 | Coroflow | $23 |
| Boston Scientific | Meals · 2025-03-13 | Avvigo Guidance System | $174 |
| Philips North America | Meals · 2025-03-13 | Coronary Other | $145 |
| Abbott Laboratories | Meals · 2025-02-28 | Triclip | $117 |
| Boston Scientific | Meals · 2025-02-27 | Comet | $65 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-11 | Jardiance | $20 |
| Abbott Laboratories | Meals · 2025-01-22 | Dragonfly Opstar | $24 |
| Boston Scientific | Meals · 2025-01-21 | Comet | $18 |
| Boston Scientific | Meals · 2025-01-08 | Avvigo Guidance System | $10 |
See earlier years (2024)
2024: $44
| iRhythm Technologies | Zio Xt Patch | $44 | 1 payment
|
Professional record
- NPI
- 1699271163
- Group
- Mohammed S Qayyum MD Inc · Dignity Health Medical Foundation
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 2577 Samaritan Dr Ste 845, San Jose, CA, 95124
- NPI first listed
- 2018-04-03
- NPI last updated
- 2025-09-08
- NPI record certified
- 2025-09-08
This is when the NPI record was last certified, not a medical board exam.